Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma
about
sameAs
Ectopic expression of the serine protease inhibitor PI9 modulates death receptor-mediated apoptosisAnaplastic lymphoma kinase: signalling in development and diseaseIntracellular serine protease inhibitor SERPINB4 inhibits granzyme M-induced cell deathLow concentrations of the soy phytoestrogen genistein induce proteinase inhibitor 9 and block killing of breast cancer cells by immune cellsRecent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family.Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.Research progresses in the pathogenesis of anaplastic large cell lymphoma.A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage.Caspase-mediated cell death in hematological malignancies: theoretical considerations, methods of assessment, and clinical implications.Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patientsEfficacy of an adapted granzyme B-based anti-CD30 cytolytic fusion protein against PI-9-positive classical Hodgkin lymphoma cells in a murine modelA new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells.Predicting the outcome in non-Hodgkin lymphoma with molecular markers.SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status.Serpins in T cell immunity.Mitochondria: gatekeepers of response to chemotherapyImmunoreactivity of CD99 in non-Hodgkin's lymphoma: unexpected frequent expression in ALK-positive anaplastic large cell lymphoma.Protein kinase networks regulating glucocorticoid-induced apoptosis of hematopoietic cancer cells: fundamental aspects and practical considerations.ALK-positive cancer: still a growing entity.Expression of granzyme B sensitizes ALK+ ALCL tumour cells to apoptosis-inducing drugs.Serpins prevent granzyme-induced death in a species-specific manner.Caspase-3 activation in systemic anaplastic large-cell lymphoma.Immune escape mechanisms in ALCL.Suppression of granzyme B activity and caspase-3 activation in leukaemia cells constitutively expressing the protease inhibitor 9.ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified.High-dose therapy and autologous stem cell transplant does not result in long-term disease-free survival in patients with recurrent chemotherapy-sensitive ALK-negative anaplastic large-cell lymphoma.Targeted ex vivo reduction of CD64-positive monocytes in chronic myelomonocytic leukemia and acute myelomonocytic leukemia using human granzyme B-based cytolytic fusion proteins.An Emerging Role for Serine Protease Inhibitors in T Lymphocyte Immunity and Beyond
P2860
Q24304892-C63EC4F4-10C9-4E47-9A21-1D48EF210926Q24312329-BC8D5150-E495-44B7-9A10-EA2C3D6117E6Q24324387-679D1625-6826-4F3E-BFD7-E4AE3A0051E3Q24656281-270B68FE-959F-4015-A955-ADD5425467C2Q30971455-4A06B575-D935-4914-A2DE-F1B42434A1BCQ33367810-CC1F0CF0-029A-4EC3-9288-3134C3EA2EA4Q33579708-74FABF67-38E5-4832-B74F-0ECDC04D3082Q34438994-20193582-65BB-453D-825D-4012F4451191Q34552993-25296862-E3B9-464D-A0AC-11260FF7EACFQ35198905-6A440034-4E35-466D-B4C5-904A64D1DACDQ36162589-05D19AE6-1D37-437E-8423-FF34878BEDA4Q36736543-B48EAD83-1397-46F8-9470-5CBA4C733B24Q36741592-14D0D889-F954-4863-B123-0B19C77E734CQ36780164-21CCF630-4953-4D48-BFF5-74C138C73614Q37119032-7BE95E03-10D0-4F08-A6AE-E0D638E713EBQ37222018-55C2805A-3131-400D-8C0F-A8C05EC7F2A9Q37347485-7AF3A306-97E4-46AD-B60C-76A61862F192Q37425836-D23CCA1F-BAC5-450D-A245-7C8157164523Q37789771-BD422C27-9402-490E-90CF-140ECC1E54FAQ38184584-49178778-79E4-4355-ACB4-DA126FEBCC7BQ38962008-AFD98FD3-49F6-4426-927B-A9E6CB3A5657Q40331824-64FBB5EC-A6EE-4EC6-B2D6-01D36280D226Q40610159-8E46D225-F953-43A5-82AC-98159D9B7A3BQ43011113-E4C52DB0-857D-4AE0-9548-1FD10B6CCA12Q44357543-CF1694E8-4A09-44ED-875C-0C9ECF1AFB15Q47366063-DEF2D43B-A7E5-4757-B6D5-7039FB0EFB29Q47990492-F1BE2652-4BDE-4E76-B19B-9451EB659C68Q53621236-D1D6B976-873B-4938-86DB-CC216D17EC6DQ58690522-5B7FFD20-CAB9-4C1A-BA41-772EC7AA618B
P2860
Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Expression levels of apoptosis ...... anaplastic large cell lymphoma
@ast
Expression levels of apoptosis ...... anaplastic large cell lymphoma
@en
Expression levels of apoptosis ...... anaplastic large cell lymphoma
@nl
type
label
Expression levels of apoptosis ...... anaplastic large cell lymphoma
@ast
Expression levels of apoptosis ...... anaplastic large cell lymphoma
@en
Expression levels of apoptosis ...... anaplastic large cell lymphoma
@nl
prefLabel
Expression levels of apoptosis ...... anaplastic large cell lymphoma
@ast
Expression levels of apoptosis ...... anaplastic large cell lymphoma
@en
Expression levels of apoptosis ...... anaplastic large cell lymphoma
@nl
P2093
P1433
P1476
Expression levels of apoptosis ...... anaplastic large cell lymphoma
@en
P2093
Bellinda A Bladergroen
C Erik Hack
Chris J L M Meijer
Danny F Dukers
Gert J Ossenkoppele
J Alain Kummer
Joost J Oudejans
Rosita L ten Berge
P304
P356
10.1182/BLOOD.V99.12.4540
P407
P577
2002-06-15T00:00:00Z